Influenza vaccination for immunocompromised patients: Systematic review and meta-analysis by etiology

Journal of Infectious Diseases

Volumn 206, Issue 8, 2012, Pages 1250-1259

  Beck, Charles R ^a   McKenzie, Bruce C ^a   Hashim, Ahmed B ^a   Harris, Rebecca C ^b   Nguyen Van Tam, Jonathan S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; PLACEBO;

ARTICLE; AUTOIMMUNE DISEASE; CANCER PATIENT; CD4+ T LYMPHOCYTE; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; FLU LIKE SYNDROME; GRAFT RECIPIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; META ANALYSIS; PRIORITY JOURNAL; PROTECTION; RESPIRATORY TRACT DISEASE; SEROCONVERSION; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT; VIREMIA;

DRUG TOXICITY; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEOPLASMS; TRANSPLANTATION; VACCINATION;

EID: 84866943629     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis487     Document Type: Article

References (49)

1. Meijer A, Lackenby A, Hungnes O, et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 2009; 15:552-60.
2. Blyth CC, Kelso A, McPhie KA, et al. The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro Surveill 2010; 15:pii = 19631.
3. Influenza (updated January 2011). In: Salisbury D, Ramsay M, Noakes K, eds. Immunisation against infectious disease. London: The Stationary Office, 2006:185-208. http://www.dh.gov.uk/en/Publicationsandsta tistics/Publications/ PublicationsPolicyAndGuidance/DH-079917. Accessed 8 August 2012.
4. Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and metaanalysis from a public health policy perspective. PLoS One 2011; 6: e29249.
5. Beck C, McKenzie B, Hashim A, Nguyen-Van-Tam J. Clinical effectiveness of influenza vaccination for immunocompromised patients: a systematic review and meta-analysis. CRD Register 2011: CRD42011001226.
6. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52:377-84. (Pubitemid 28438523)
7. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.0.2 (updated September 2009).The Cochrane Collaboration, Chichester, UK, 2009.
8. West S, King V, Carey T, et al. Systems to rate the strength of scientific evidence. Evidence report/technology appraisal number 47. Agency for Healthcare Research and Quality, Rockville, MD, 2002.
9. Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. London, United Kingdom: European Agency for the Evaluation of Medicinal Products, 1997.
10. ICH Expert Working Group. ICH harmonised tripartite guideline: guideline for good clinical practice E6(R1). http://www.ich.org/fileadmin/Public-Web-Site/ ICH-Products/Guidelines/Effi615cacy/E6-R1/Step4/E6-R1-Guideline.pdf. Accessed 19 November 2011.
11. Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. York, United Kingdom: Centre for Reviews and Dissemination, University of York, 2008.
12. Ranieri R, Veronelli A, Santambrogio C, Pontiroli AE. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. AIDS Res Human Retroviruses 2005; 21: 407-9. (Pubitemid 40800457)
13. Tasker SA, Treanor JJ, Paxton WB, Wallace MR. Efficacy of influenza vaccination in HIV-infected persons: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131:430-3. (Pubitemid 29444433)
14. Anema A, Mills E, Montaner J, Brownstein JS, Cooper C. Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 2008; 9:57-61.
15. Atashili J, Kalilani L, Adimora AA. Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis 2006; 6:138.
16. Yamanaka H, Teruya K, Tanaka M, et al. Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients. J Acquir Immune Defic Syndr 2005; 39:167-73. (Pubitemid 40741114)
17. Gunthard HF, Wong JK, Spina CA, et al. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis 2000; 181:522-31. (Pubitemid 30131819)
18. Rosok B, Voltersvik P, Bjerknes R, Axelsson M, Haaheim LR, Asjo B. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol 1996; 104:203-7. (Pubitemid 26139775)
19. Banic S, Koren S, Tomazic J, et al. Influenza vaccination of human immunodeficiency virus 1-infected patients receiving antiretroviral therapy. Acta Virol 2001; 45:39-44. (Pubitemid 32448416)
20. Vigano A, Bricalli D, Trabattoni D, et al. Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha. AIDS Res Human Retroviruses 1998; 14:727-34. (Pubitemid 28265733)
21. Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182:1727-37.
22. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86:1082-9.
23. Tasker SA, O'Brien WA, Treanor JJ, et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine 1998; 16:1039-42. (Pubitemid 28276020)
24. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res 1971; 31:420-6.
25. Esposito S, Cecinati V, Scicchitano B, et al. Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine 2010; 28:1558-65.
26. de Lavallade H, Garland P, Sekine T, et al. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica 2011; 96:307-14.
27. Mazza JJ, Yale SH, Arrowood JR, et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005; 3:214-20.
28. Schafer AI, Churchill WH, Ames P, Weinstein L. The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 1979; 43:25-30. (Pubitemid 9131104)
29. Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF. Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol 2003; 70:225-30. (Pubitemid 36469759)
30. Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatr Blood Cancer 2010; 54:716-20.
31. Antonio R, Delogu G, Sali M, et al. Efficacy of influenza A(H1N1v) vaccination in children with cancer. Pediatr Blood Cancer 2010; 55:973.
32. Xu Y, Methuku N, Coimbatore P, et al. A prospective study of the immunogenicity of inactivated influenza A (H1N1) 2009 monovalent vaccine in patients who have solid or hematologic malignancies. In: 48th Annual Meeting of the Infectious Diseases Society of America; 21-24 October 2010; Vancouver, Canada. Abstract 5075, poster LB-13.
33. Yalçin SS, Kondolot M, Albayrak N, et al. Serological response to influenza vaccine after hematopoetic stem cell transplantation. Ann Hematol 2010; 89:913-8.
34. Thibault F, Noble CP, Morelon E, et al. Safety and efficacy of an inactivated, unadjuvanted vaccine adainst the novel influenza A variant (H1N1v) in renal transplant recipients (Transfluvac study). In: Options for the Control of Influenza VII; 3-7 September 2010; Hong Kong, SAR, China. Poster P573.
35. Madan RP, Tan M, Fernandez-Sesma A, et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008; 46:712-8. (Pubitemid 351321555)
36. Dopp JM, Wiegert NA, Moran JJ, et al. Effect of annual influenza immunization on antibody response in lung transplant patients. Prog Transplant 2009; 19:153-9.
37. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8:332-7.
38. Del Porto F, Lagana B, Biselli R, et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006; 24:3217-23.
39. Holvast A, van Assen S, de Haan A, et al. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology 2009; 48:1294-9.
40. Lu CC, Wang YC, Lai JH, Lee TSH, Lin HT, Chang DM. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 2011; 29:444-50.
41. Wiesik-Szewczyk E, Romanowska M, Mielnik P, et al. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol 2010; 29:605-13.
42. Zykov MP, Rafaelskaya TI, Volkon VM, Knoring BE, Shenderova RI, Baymakova EA. Influenza virus vaccination of patients with pulmonary tuberculosis. Problemy Tuberkuleza 1980; 58:3-5.
43. Kostyanaya IE, Meisner AF, Aksenova VA, Baturo AP. Experience in administration of the vaccines "Pneumo 23" and "VAXIGRIP" among children at risk infected with Mycobacterium tuberculosis. Bulleten Vakzinazija 2002; 1.[epub]. http://medi.ru/doc/15b1906.htm. Accessed 8 August 2012.
44. Hanania NA, Sockrider M, Castro M, et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 2004; 113:717-24. (Pubitemid 38530429)
45. Kubiet MA, Gonzalez-Rothi RJ, Cottey R, Bender BS. Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest 1996; 110:367-70. (Pubitemid 26269262)
46. Nicholson K, Nguyen-Van-Tam J, Ahmed A, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998; 351:326-31. (Pubitemid 28052698)
47. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98:196-200. (Pubitemid 26262129)
48. Reid DW, Bromly CL, Stenton SC, Hendrick DJ, Bourke SJ. A doubleblind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma. Respir Med 1998; 92:1010-1. (Pubitemid 28416829)
49. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.